The regime’s embarrassment should be increasing now that other countries are reporting that Thailand’s AstraZeneca production is severely delayed.
Reuters reports that, in addition to the Philippines, both Malaysia and Taiwan are saying deliveries of AstraZeneca vaccines manufactured in Thailand will be delayed. AstraZeneca reportedly made the king’s Siam Bioscience the production site for much of Southeast Asia.

Clipped from The Rand Blog
The report states that “AstraZeneca’s distribution plans in Southeast Asia … depends on 200 million doses made by Siam Bioscience, a company owned by Thailand’s king that is making vaccines for the first time.” It adds:
Any questions about Siam Bioscience meeting production targets are sensitive because King … Vajiralongkorn is its sole owner. Insulting Thailand’s monarchy is a crime punishable by up to 15 years in prison….
Siam Bioscience and AstraZeneca did not immediately respond to requests for comment….
In Taiwan, Health Minister Chen Shih-chung said “orders from AstraZeneca would be delayed by a month due to production problems at the firm’s Thai plant.”
In Malaysia, Science Minister Khairy Jamaluddin told reporters he is also expecting delays.
In Thailand, Thai Enquirer reports that
A source inside Thailand’s Ministry of Public Health told Thai Enquirer that part of the reason for the delay is because the Thai government has decided to focus first on inoculating its own citizens.
“I think the government has been criticized from all sides due to its decision to heavily rely on SBS vaccines and it is especially sensitive right now,” the source told Thai Enquirer by phone.
“So they are halting or delaying exports of the vaccine to focus on the inoculation drive to gain back some credit.”
Remember when Health Minister Anutin Charnvirakul was demanding that AstraZeneca deliver doses to Thailand as contracted? What’s he saying now? Such “vaccine nationalism” has been seen elsewhere, but what about contracts?
Meanwhile, even in Bangkok, the supply of vaccines continues to run short. But the private sector seems to be able to access a flow of vaccines. What’s going on?
Leave a Reply